Answers are grounded in this paper and cite their sources.
The gyrA and parC genes of 31 clinical isolates of Enterococcus faecalis, including fluoroquinolone-resistant isolates, were partially sequenced and analyzed for target alterations. Topoisomerase IV may be a primary target in E. faecalis, but high-level fluoroquinolone resistance was associated with simultaneous alterations in both GyrA and ParC.
No takes yet. Share an insight, caveat, or question.
Kanematsu et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: